1,721,015 research outputs found

    Commentary: second ipsilateral metachronous lung cancer: what to do?

    No full text
    The article by Hattori and colleagues1 deals with an interesting and still not sufficiently explored issue in thoracic surgery: the role of repeated anatomic resection for radical treatment of second metachronous ipsilateral non–small cell lung cancer (NSCLC

    Stenting treatment is a minimally traumatic and effective alternative to surgical repair for iatrogenic tracheobronchial lesion

    Full text link
    Iatrogenic tracheobronchial injuries are rare but lifethreatening events, most frequently due to complication of endotracheal intubation or percutaneous tracheostomy. Their incidence is low (0.005–0.2% after double lumen or emergency single lumen intubation and up to 0.7% after percutaneous tracheostomy), but related mortality can be high and has been generally reported between 11% and 42% (1-5). Surgical repair has been considered the treatment of choice for a long time. More recently, along with the progressive evolution of interventional bronchoscopy, minimally invasive endoscopic treatment has gained diffusion as an effective alternative

    The role of lymphadenectomy in lung cancer surgery

    No full text
    Adequate lymphadenectomy represents a fundamental procedure in lung cancer surgery for accurate staging and potential survival benefit. Various techniques are used in current surgical practice for the intraoperative lymph node removal associated with pulmonary resection, without definitive indications concerning the preferable option. Different studies in the last decades have compared complete mediastinal lymph node dissection with lymph node sampling regarding their effect on long-term survival, recurrence rate, accuracy of pathologic staging, and surgical morbidity. Literature data and technical aspects of lymph node dissection are reported and discussed in this article

    Empiema pleurico

    No full text
    corecore